Literature DB >> 3162735

Cerebrospinal fluid lymphocytes from HIV-infected patients synthesize HIV-specific antibody in vitro.

A Amadori1, A De Rossi, P Gallo, B Tavolato, L Chieco-Bianchi.   

Abstract

Cerebrospinal fluid lymphocytes from six human immunodeficiency virus (HIV)-infected and three seronegative patients were studied for in vitro synthesis of HIV-specific antibody by means of Western blot analysis of lymphocyte culture supernatants. All the HIV-positive subjects showed in vitro production of HIV-specific IgG, regardless of neurological involvement, while no specific antibody synthesis was detected in seronegative individuals. These data provide the first direct evidence that HIV-specific antibody in cerebrospinal fluid is due to intrathecal synthesis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3162735     DOI: 10.1016/0165-5728(88)90065-3

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  4 in total

1.  Class differentiation of immunoglobulin-containing cerebrospinal fluid cells in inflammatory diseases of the central nervous system.

Authors:  P Rieckmann; T Weber; K Felgenhauer
Journal:  Klin Wochenschr       Date:  1990-01-04

2.  Immune activation and viral burden in acute disease induced by simian immunodeficiency virus SIVsmmPBj14: correlation between in vitro and in vivo events.

Authors:  R Schwiebert; P N Fultz
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

3.  Protective role of the virus-specific immune response for development of severe neurologic signs in simian immunodeficiency virus-infected macaques.

Authors:  S Sopper; U Sauer; S Hemm; M Demuth; J Müller; C Stahl-Hennig; G Hunsmann; V ter Meulen; R Dörries
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

Review 4.  Compartmentalized intrathecal immunoglobulin synthesis during HIV infection - a model of chronic CNS inflammation?

Authors:  Mickael Bonnan; Bruno Barroso; Stéphanie Demasles; Elsa Krim; Raluca Marasescu; Marie Miquel
Journal:  J Neuroimmunol       Date:  2015-05-16       Impact factor: 3.478

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.